Survival benefit of preoperative hepatic arterial infusion of oxaliplatin, fluorouracil, and leucovorin followed by hepatectomy for hepatocellular carcinoma

Survival benefit of preoperative hepatic arterial infusion of oxaliplatin, fluorouracil, and leucovorin followed by hepatectomy for hepatocellular carcinoma

Background: Hepatic arterial infusion chemotherapy (HAIC) with cisplatin, fluorouracil, and leucovorin (FOLFOX) demonstrated promising efficacy against advanced hepatocellular carcinoma (HCC) as an alleviative treatment. We aimed to explore the survival benefit of preoperative FOLFOX-HAIC and establ...

Full description

Bibliographic Details
Main Authors: Zili Hu, Zhenyun Yang, Yangxun Pan, Yizhen Fu, Jiongliang Wang, Zhongguo Zhou, Minshan Chen, Dandan Hu, Yaojun Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-06-01
Series:Frontiers in Pharmacology
Subjects:
hepatic arterial infusion chemotherapy (HAIC)
hepatocellular carcinoma (HCC)
preoperative treatment
FOLFOX
nomogram
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2023.1210835/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2023.1210835/full

Similar Items